Skip to main content
International Journal of Ophthalmology logoLink to International Journal of Ophthalmology
. 2011 Aug 18;4(4):449–451. doi: 10.3980/j.issn.2222-3959.2011.04.25

Choroidal neovascularization and angioid streaks in pseudoxanthoma elasticum

Melisa Nika 1, Cagri G Besirli 1
PMCID: PMC3340877  PMID: 22553699

Abstract

AIM

To report a case of pseudoxanthoma elasticum (PXE) in a 48 year old woman that presented with bilateral blurry vision.

METHODS

A case report

RESULTS

A 48-year-old woman presented with bilateral blurry vision and right eye metamorphopsia. The patient had a history of angioid streaks in the left eye ten years ago for which she had received laser surgery and had poor residual vision. Visual acuity was 20/60 in the right eye and count fingers at 6 feet in the left. Fundus examination showed subretinal hemorrhage and macular thickening on the right and a disciform macular scar with focal atrophic pigment epithelial lesions on the left. Both eyes had angioid streaks and peau d'orange pigmentary pattern of the retina. External examination showed several, yellow skin papules and plaques on the lateral and posterior neck, as well as prominent mental creases. Pathologic examination of skin biopsy confirmed the diagnosis of PXE, showing calcium deposition and fragmented, clumped elastic fibers in the deep reticular dermis. She responded well to intravitreal bevacizumab injections and visual acuity improved to 20/25 OD. Preventative care was emphasized and the patient was referred to cardiology, gastroenterology and human genetics for counseling.

CONCLUSION

PXE is a multisystem disorder affecting the dermatologic, ocular, and cardiovascular systems. Ophthalmic findings of angioid streaks and choroidal neovascularization in the presence of stereotypical skin changes and prominent mental creases should prompt evaluation for PXE.

Keywords: angioid streaks, pseudoxanthoma elasticum, peau d'orange

INTRODUCTION

Pseudoxanthoma elasticum (PXE) is a multisystem disorder affecting the tegumentary, ocular, and cardiovascular systems. It is characterized by progressive calcification and fragmentation of elastic fibers[1], [2]. Early recognition is essential for decreasing the risk of systemic complications.

CASE REPORT

A 48-year-old woman presented with bilateral blurry vision and right eye metamorphopsia of one week duration. She had no associated symptoms. The patient had a history of angioid streaks in the left eye ten years ago for which she had received laser treatment and had poor residual vision.

On ocular examination, her visual acuity was 20/60 in the right eye and count fingers at 6 feet on the left. Visual fields examination was full to counting fingers. Anterior segment examination showed quiet anterior chambers bilaterally. Fundus examination showed subretinal hemorrhage and macular thickening on the right (Figure 1) and a disciform macular scar (Figure 2) with focal atrophic pigment epithelial lesions on the left. Both eyes had angioid streaks (arrowheads) and peau d'orange pigmentary pattern of the retina (stars). External examination showed several, yellow skin papules and plaques on the lateral and posterior neck (Figure 3). The patient was noted to have prominent mental creases (Figure 4).

Figure 1. The right eye: subretinal hemorrhage (arrow), angioid streaks (arrowheads), peau d'orange pigmentary pattern of the retina (stars).

Figure 1

Figure 2. The left eye: disciform macular scar (arrow), angioid streaks (arrowheads), peau d'orange pigmentary pattern of the retina (stars).

Figure 2

Figure 3. Lateral neck: several skin papules.

Figure 3

Figure 4. Prominent mental creases.

Figure 4

Based on ocular and dermatologic findings, the patient was clinically diagnosed with PXE. Pathologic examination of a skin biopsy specimen from her neck showed calcium deposition (Figure 5) and fragmented, clumped elastic fibers in the deep reticular dermis (Figure 6), confirming the diagnosis of PXE.

Figure 5. Calcium deposition in the deep reticular dermis (Von kossa stain 40x magnification).

Figure 5

Figure 6. Fragmented clumped elastic fibers in the deep reticular dermis (Movat stain 40x magnification).

Figure 6

The patient received intravitreal bevacizumab injections every six weeks and visual acuity improved to 20/25 in the right eye. Preventative care was emphasized and she was referred to cardiology, gastroenterology, and genetic counseling.

DISCUSSION

PXE is an inherited disorder that affects the dermatologic, ocular, and cardiovascular systems. It is characterized by degeneration and fragmentation of elastic fibers due to progressive calcification[1], [3]. Recent studies suggest that PXE is inherited in an autosomal recessive fashion. Mutations in the ABCC6 gene on chromosome 16p13.1 have been connected to the disease. ABCC6 gene encodes multidrug resistance associated protein 6 (MRP6), a transmembrane transporter protein with no known exact biological function[3], [4]. Faulty expression of MRP6 results in accumulation of substances with an affinity for elastic fibers, which causes clumping of elastic fibers in target tissues and calcium deposition.

In skin the pathology happens mostly in the deep reticular dermis. This leads to cutaneous lesions with the appearance of small yellow papules that may coalesce into plaques giving the skin a “plucked chicken” appearance and typically develop on the neck and flexural areas[2]. Recently, Lebwohl et al[5] reported the strong association of prominent mental creases and PXE. This stereotypical skin finding was very prominent in our patient and increased our clinical suspicion for the diagnosis of PXE in this case.

The characteristic ocular sign, angioid streaks, results from degeneration and calcification of the elastic fibers of the retina leading to breaks in Bruch's membrane. This can lead to choroidal neovascularization (CNV), subretinal and retinal hemorrhages, progressive visual loss and legal blindness. Typical age of onset of angioid streaks is between 15 and 25 years. However, the first ocular sign is often peau d'orange appearance of the retina, which may precede angioid streaks by 10 years[6].

Cardiovascular manifestations, due to calcium deposition and degeneration of elastic laminae of medium sized arteries, comprise a serious aspect of the disease process. Clinically this may present as intermittent claudication, renovascular hypertension, coronary artery disease, stroke, mitral valve stenosis or prolapse. Gastrointestinal hemorrhage is experienced by approximately 10% of PXE patients, due to the brittle calcified submucosal vessels[7], [8].

It is of paramount importance to recognize PXE early, in order to reduce morbidity and mortality from systemic complications. Ophthalmic findings of angioid streaks and choroidal neovascularization in the presence of stereotypical skin changes and prominent mental creases should prompt evaluation for PXE.

Management requires a multidisciplinary approach (dermatologist, primary care physician, ophthalmologist, cardiologist, medical geneticists), routine examination by a retina specialist, regular use of the Amsler grid, routine physical examination with attention to the cardiovascular system, periodic monitoring of serum lipids and for gastrointestinal bleeding[1],[2],[9].

Therapeutic approaches for ocular complications include laser photocoagulation and intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors. Laser photocoagulation has been shown to arrest the progression of CNV, however this has been associated with a high rate of recurrence as well as scarring and subsequent vision loss[10]. As demonstrated in our patient, repeated intravitreal injections of anti-VEGF, such as bevacizumab and ranibizumab, have been shown to be effective in treating CNVs, preserving and recovering vision[11]-[13].

REFERENCES

  • 1.Laube S, Moss C. Pseudoxanthoma elasticum. Arch Dis Child. 2005;90(7):754–756. doi: 10.1136/adc.2004.062075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Robert P. Finger, Peter Charbel Issa, Ladewig MS, Götting C, Szliska C, Scholl HP, Holz FG. Pseudoxanthoma Elasticum: Genetics, Clinical Manifestations and Therapeutic Approaches. Survey of Ophthalmology. 2009;54(2):272–285. doi: 10.1016/j.survophthal.2008.12.006. [DOI] [PubMed] [Google Scholar]
  • 3.Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet. 2005;42(12):881–892. doi: 10.1136/jmg.2004.030171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA. 2000;97:6001–6006. doi: 10.1073/pnas.100041297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lebwohl M, Lebwohl E, Bercovitch L. Prominent mental (chin) crease: a new sign of pseudoxanthoma elasticum. J Am Dermatol. 2003;48(4):620–622. doi: 10.1067/mjd.2003.195. [DOI] [PubMed] [Google Scholar]
  • 6.Hacker SM, Ramos-Caro FA, Beers BB, Flowers FP. Juvenile pseudoxanthoma elasticum: recognition and management. Pediatr Dermatol. 1993;10:19–25. doi: 10.1111/j.1525-1470.1993.tb00005.x. [DOI] [PubMed] [Google Scholar]
  • 7.Antiga E, Melani L, Caproni M, Fabbri P. An unusual cause of gastrointestinal bleeding in a young girl. CMAJ. 2006;175(6):583. doi: 10.1503/cmaj.060411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Reinertson RP, Farber EM. Pseudoxanthoma elasticum with gastrointestinal bleeding. Calif Med. 1955;83(2):94–99. [PMC free article] [PubMed] [Google Scholar]
  • 9.Terry SF, Bercovitch L. Seattle (WA): University of Washington, Seattle; 1993-2001. Pseudoxanthoma Elasticum. GeneReviews[Internet] [Google Scholar]
  • 10.Pece A, Avanza P, Galli L, Brancato R. Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina. 1997;17:12–16. doi: 10.1097/00006982-199701000-00003. [DOI] [PubMed] [Google Scholar]
  • 11.Finger RP, Charbel Issa P, Ladewig M, Holz FG, Scholl HP. Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum. Br J Ophthalmol. 2008;92(4):483–487. doi: 10.1136/bjo.2007.129916. [DOI] [PubMed] [Google Scholar]
  • 12.Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D. Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks. Ophthalmologe. 2007;104:325–813. doi: 10.1007/s00347-006-1456-y. [DOI] [PubMed] [Google Scholar]
  • 13.Myung JS, Bhatnagar P, Spaide RF, Klancnik JM Jr, Cooney MJ, Yannuzzi LA, Freund KB. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina. 2010;30(5):748–755. doi: 10.1097/IAE.0b013e3181c596b1. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Ophthalmology are provided here courtesy of Press of International Journal of Ophthalmology

RESOURCES